T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...

Sweden’s Mendus (STO: IMMU), a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief ...

The introduction of outpatient flat-rate payments approved today by the Swiss Federal Council poses significant risks for ...

In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in ...

US biotech Biohaven last week received a commitment from Oberland Capital to invest up to $600 million in the company. Also, ...

Kissei Pharmaceutical is a Japanese research and development focused corporation. It aims to push advances in cutting-edge research in areas such as biotechnology-based medicine and even further ...

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...

The global dermatological cell and gene therapy (CGT) market is poised for exceptional growth at a compound annual growth ...

Danish drugmaker Novo Nordisk (NOV: N) has secured a significant advantage in the high-stakes obesity drug market after ...

Anglo-Swedish pharma major AstraZeneca has presented positive top-line results from the Phase III KALOS and LOGOS trials in ...